Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Debt / NOTE 4.000%11/1
-
Number of holders
-
9
-
Total 13F principal, excl. options
-
28.7M
-
Principal change
-
+7.63M
-
Total reported value, excl. options
-
$41M
-
Value change
-
+$186K
-
Number of buys
-
4
-
Number of sells
-
-2
-
Price
-
$1.00
Significant Holders of ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q3 2025
11 filings reported holding 29664WAB1 - ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q3 2025.
ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 has 9 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $28.7M of principal
.
Largest 10 bondholders include Pentwater Capital Management LP ($10.9M of principal), DeepCurrents Investment Group LLC ($8.4M of principal), PenderFund Capital Management Ltd. ($3M of principal), OAKTREE CAPITAL MANAGEMENT LP ($2.11M of principal), Jefferies Financial Group Inc. ($1.75M of principal), Russell Investments Group, Ltd. ($1.69M of principal), Saranac Partners Ltd ($500K of principal), ZAZOVE ASSOCIATES LLC ($375K of principal), Context Capital Management, LLC ($12.4K of principal), and DCF Advisers, LLC ($0 of principal).
This table shows the top 9 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.